Kraj: Irlandia
Język: angielski
Źródło: HPRA (Health Products Regulatory Authority)
BHV-1 STRAIN GK/D INACTIVATED GLYCOPROTEIN E DEFICIENT (GE) BOVINE HERPESVIRUS 1
Intervet Ireland Limited
QI02AA03
BHV-1 STRAIN GK/D INACTIVATED GLYCOPROTEIN E DEFICIENT (GE) BOVINE HERPESVIRUS 1
60 Elisa Units
Suspension for Injection
POM(E)
Bovine
Bovine rhinotracheitis virus vaccine (IBR)
Immunological - Inactivated vaccine
Authorised
2006-07-05
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Bovilis IBR marker inac Suspension for injection for cattle. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Suspension for injection. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For active immunisation of cattle to reduce the intensity and duration of clinical signs (pyrexia) induced by an infection with BHV-1 as well as to reduce the replication and nasal excretion of the field virus. Onset of immunity: 3 weeks after basic vaccination Duration of immunity: 6 months after basic vaccination 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Efficacy has not been demonstrated in the face of maternally derived antibodies. _per dose of 2 ml:_ ACTIVE SUBSTANCE: Inactivated antigen of BHV-1 (gE) strain GK/D 60 Elisa units for induction of 6.1 - 11.1 log 2 VN-units* in mouse potency test. ADJUVANT: Al3+ (as Aluminium-phosphate and -hydroxide) 6.0-8.8 mg EXCIPIENT: Formaldehyde 0.03 - 0.05% *virus neutralising units For a full list of excipients, see section 6.1 IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 17/08/2011_ _CRN 7010409_ _page number: 1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Vaccinate only healthy animals. SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE VETERINARY MEDICINAL PRODUCT TO ANIMALS In the case of accidental self-injection, seek medical advice immediately and show the package leaflet or label to the physician. 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) Occasionally a hypersensitivity reaction may occur. In such cases an appropriate symptomatic treatment should b Przeczytaj cały dokument